J. Paul Abernathy - 16 Feb 2024 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
Director
Signature
/s/ J. Paul Abernathy by Kristina R. Hulsey, P.O.A.
Issuer symbol
NHC
Transactions as of
16 Feb 2024
Net transactions value
+$125,012
Form type
4
Filing time
21 Feb 2024, 17:21:06 UTC
Previous filing
08 Jan 2024
Next filing
13 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHC Shares of Common Stock Options Exercise $125,012 +1,745 +5.3% $71.64 34,883 16 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock [2021 Grant] Options Exercise $0 -1,745 -23% $0.000000 5,755 16 Feb 2024 Common Stock 7,500 $71.64 Direct F1
holding NHC Option to Purchase Common Stock [2022 Grant] 7,500 16 Feb 2024 Common Stock 7,500 $69.19 Direct
holding NHC Option to Purchase Common Stock [2023 Grant] 7,500 16 Feb 2024 Common Stock 7,500 $55.75 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).